Call:
+7 771 977 66 65, +7 705 421 2277
Sign in
or
Register
My basket
Astana Biomed Group, an authorized Abcam distributor in Central Asia
Abiomed homepage
Categories
Signal Transduction
Cancer
Epigenetics and Nuclear Signaling
Immunology
Cell Biology
Cardiovascular
Neuroscience
Tags & Cell Markers
Kits/ Lysates/ Other
Developmental Biology
Microbiology
Biochemicals
Secondary antibodies
Isotype/Loading Controls
Antibody Arrays
About us
Partners
Contact
Address
Saryarka 32, 18, 010000, Astana city, Kazakhstan
Telephone
+7 771 977 66 65, +7 705 421 2277
Email
laboratory@ctlab.kz, orders@abiomed.kz
Chemokines
Sort by
Relevance
Recently added
Alphabetical order
[D-Lys3]-GHRP-6 (DLS), Ghrelin receptor (GHS-R1a) and CCR5 antagonist (ab141148)
Description:
Ghrelin receptor (GHS-R1a) and CCR5 antagonist
Application:
Reactivity:
Conjugate:
Luteolin, Antioxidant and anti-inflammatory (ab120662)
Description:
Antioxidant, anti-inflammatory, anticancer flavonoid
Application:
Reactivity:
Conjugate:
SB 297006, CCR3 antagonist (ab120821)
Description:
Potent, selective CCR3 antagonist
Application:
Reactivity:
Conjugate:
SB 328437, CCR3 antagonist (ab120648)
Description:
Highly potent and selective CCR3 antagonist
Application:
Reactivity:
Conjugate:
(+)-Abscisic acid, Phytohormone (ab120860)
Description:
Phytohormone; produced by a variety of cells in humans and animals
Application:
Reactivity:
Conjugate:
(±)-Lisofylline, Anti-inflammatory agent (ab141693)
Description:
Anti-inflammatory agent.
Application:
Reactivity:
Conjugate:
DAPTA, CCR5 antagonist (ab120810)
Description:
Potent, selective CCR5 antagonist
Application:
Reactivity:
Conjugate:
FC 131, CXCR4 activation inhibitor (ab230363)
Description:
An inhibitor of CXCR4 activation
Application:
Reactivity:
Conjugate:
Human CXCL10 (IP10) knockout THP-1 cell line (ab277860)
Description:
Human CXCL10 (IP10) knockout THP-1 cell line
Application:
Reactivity:
Conjugate:
Recombinant Human CCR4 protein (ab253173)
Description:
Application:
Reactivity:
Conjugate:
‹
1
2
...
80
81
82
83
84
85
86
87
88
89
›
Get resources and offers direct to your inbox
Sign up